サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1260754

CSF (豚熱) ワクチンの世界市場の分析 (2023年)

Global Classical Swine Fever Vaccines Market Research Report 2023
出版日: | 発行: QYResearch | ページ情報: 英文 159 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.25円
CSF (豚熱) ワクチンの世界市場の分析 (2023年)
出版日: 2023年04月20日
発行: QYResearch
ページ情報: 英文 159 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のCSF (豚熱) ワクチンの市場規模は、2022年に1億5,470万米ドルとなり、2029年には2億1,100万米ドルに達すると予測され、予測期間中 (2023年～2029年) に4.6%のCAGRで成長する見通しです。

北米のCSF (豚熱) ワクチンの市場規模は、2023年の1,229万米ドルから、2029年には1,486万米ドルに達し、予測期間中 (2023年～2029年) に3.22%のCAGRで成長すると予測されます。

アジア太平洋のCSF (豚熱) ワクチンの市場規模は、2023年の1億400万米ドルから、2029年には1億4,070万米ドルに達し、予測期間中 (2023年～2029年) に5.17%のCAGRで成長すると予測されています。

世界のCSF (豚熱) ワクチンの主要メーカーには、WINSUN、Boehringer Ingelheim、CAHIC、SPAH、Merck、Ceva、Harbin Veterinary Research Institute、Qilu Animal Health Products Factoryなどがあります。2022年には、世界の上位ベンダー5社で、収益ベースで約50.49%のシェアを占めています。

目次

第1章 CSF (豚熱) ワクチン：市場概要

  • 製品の定義
  • CSF (豚熱) ワクチン：由来別
    • 世界のCSF (豚熱) ワクチンの市場金額：由来別の比較 (2023年～2029年)
    • 組織培養由来
    • 細胞株由来
  • CSF (豚熱) ワクチン：販売チャネル別
    • 世界のCSF (豚熱) ワクチンの市場金額：販売チャネル別 (2023年～2029年)
    • 政府入札
    • 市場販売
  • 世界のCSF (豚熱) ワクチンの市場規模、推定・予測
    • 世界のCSF (豚熱) ワクチンの収益 (2018年～2029年)
    • 世界のCSF (豚熱) ワクチンの販売 (2018年～2029年)
    • 世界のCSF (豚熱) ワクチンの平均市場価格 (2018年～2029年)
  • 前提・制約条件

第2章 市場競合：メーカー別

  • 世界のCSF (豚熱) ワクチンの販売の市場シェア：メーカー別 (2018年～2023年)
  • 世界のCSF (豚熱) ワクチンの収益の市場シェア：メーカー別 (2019年～2023年)
  • 世界のCSF (豚熱) ワクチンの平均価格：メーカー別 (2019年～2023年)
  • 世界のCSF (豚熱) ワクチンの主要企業：業界ランキング (2021年・2022年)
  • 世界のCSF (豚熱) ワクチンの主要メーカー：提供エリア・本社
  • 世界のCSF (豚熱) ワクチンの主要メーカー：製品種類と用途
  • 世界のCSF (豚熱) ワクチンの主要メーカー：設立時期
  • 世界のCSF (豚熱) ワクチン市場：競争状況と動向

第3章 世界のCSF (豚熱) ワクチン市場のシナリオ：地域別

  • 世界のCSF (豚熱) ワクチンの市場規模：地域別 (2018年・2022年・2029年)
  • 世界のCSF (豚熱) ワクチンの販売：地域別 (2018年～2029年)
  • 世界のCSF (豚熱) ワクチンの収益：地域別 (2018年～2029年)
  • 北米のCSF (豚熱) ワクチン市場の事実と数値：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州のCSF (豚熱) ワクチン市場の事実と数値：国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
  • アジア太平洋のCSF (豚熱) ワクチン市場の事実と数値：地域別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 東南アジア
  • 南米のCSF (豚熱) ワクチン市場の事実と数値：国別
    • ブラジル
  • 中東・アフリカのCSF (豚熱) ワクチン市場の事実と数値：国別
    • 中東
    • アフリカ

第4章 セグメント：由来別

  • 世界のCSF (豚熱) ワクチンの販売：由来別 (2018年～2029年)
  • 世界のCSF (豚熱) ワクチンの収益：由来別 (2018年～2029年)
  • 世界のCSF (豚熱) ワクチンの価格：由来別 (2018年～2029年)

第5章 セグメント：販売チャネル別

  • 世界のCSF (豚熱) ワクチンの販売：販売チャネル別 (2018年～2029年)
  • 世界のCSF (豚熱) ワクチンの収益：販売チャネル別 (2018年～2029年)
  • 世界のCSF (豚熱) ワクチンの価格：販売チャネル別 (2018年～2029年)

第6章 主要企業のプロファイル

  • WINSUN
  • Boehringer Ingelheim
  • CAHIC
  • SPAH
  • Merck
  • Ceva
  • Harbin Veterinary Research Institute
  • Qilu Animal Health Products Factory
  • Ringpu Biology
  • DHN
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • Jinyu Bio-Technology
  • Institutul Pasteur
  • MVP
  • Tecon

第7章 産業チェーンと販売チャネルの分析

  • CSF (豚熱) ワクチンの産業チェーンの分析
  • CSF (豚熱) ワクチンの主要原材料
  • CSF (豚熱) ワクチンの製造モードとプロセス
  • CSF (豚熱) ワクチンの販売とマーケティング
  • CSF (豚熱) ワクチンの顧客

第8章 CSF (豚熱) ワクチンの市場力学

  • CSF (豚熱) ワクチン業界の動向
  • CSF (豚熱) ワクチン市場の促進要因
  • CSF (豚熱) ワクチン市場の課題
  • CSF (豚熱) ワクチン市場の抑制要因

第9章 調査結果と結論

第10章 調査手法とデータソース

図表

List of Tables

  • Table 1. Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029) & (US$ Million)
  • Table 2. Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029) & (US$ Million)
  • Table 3. Global Classical Swine Fever Vaccines Market Competitive Situation by Manufacturers in 2022
  • Table 4. Global Classical Swine Fever Vaccines Sales (M Doses) of Key Manufacturers (2019-2023)
  • Table 5. Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2019-2023)
  • Table 6. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Manufacturers (2019-2023)
  • Table 7. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers (2019-2023)
  • Table 8. Global Market Classical Swine Fever Vaccines Average Price (US$/K Doses) of Key Manufacturers (2019-2023)
  • Table 9. Global Key Players of Classical Swine Fever Vaccines, Industry Ranking, 2021 VS 2022
  • Table 10. Global Key Manufacturers of Classical Swine Fever Vaccines, Area Served & Headquarters
  • Table 11. Global Key Manufacturers of Classical Swine Fever Vaccines, Product Type & Application
  • Table 12. Founded Data of Global Key Classical Swine Fever Vaccines Manufacturers
  • Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Classical Swine Fever Vaccines as of 2022)
  • Table 15. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 16. Global Classical Swine Fever Vaccines Sales by Region (2018-2023) & (M Doses)
  • Table 17. Global Classical Swine Fever Vaccines Sales Market Share by Region (2018-2023)
  • Table 18. Global Classical Swine Fever Vaccines Sales by Region (2024-2029) & (M Doses)
  • Table 19. Global Classical Swine Fever Vaccines Sales Market Share by Region (2024-2029)
  • Table 20. Global Classical Swine Fever Vaccines Revenue by Region (2018-2023) & (US$ Million)
  • Table 21. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2018-2023)
  • Table 22. Global Classical Swine Fever Vaccines Revenue by Region (2024-2029) & (US$ Million)
  • Table 23. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2024-2029)
  • Table 24. North America Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 25. North America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
  • Table 26. North America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
  • Table 27. North America Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million)
  • Table 28. North America Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million)
  • Table 29. Europe Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 30. Europe Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
  • Table 31. Europe Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
  • Table 32. Europe Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million)
  • Table 33. Europe Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million)
  • Table 34. Asia Pacific Classical Swine Fever Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 35. Asia Pacific Classical Swine Fever Vaccines Sales by Region (2018-2023) & (M Doses)
  • Table 36. Asia Pacific Classical Swine Fever Vaccines Sales by Region (2024-2029) & (M Doses)
  • Table 37. Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2018-2023) & (US$ Million)
  • Table 38. Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2024-2029) & (US$ Million)
  • Table 39. South America Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 40. South America Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
  • Table 41. South America Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
  • Table 42. South America Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million)
  • Table 43. South America Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million)
  • Table 44. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 45. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2023) & (M Doses)
  • Table 46. Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2024-2029) & (M Doses)
  • Table 47. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2018-2023) & (US$ Million)
  • Table 48. Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2024-2029) & (US$ Million)
  • Table 49. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2018-2023)
  • Table 50. Global Classical Swine Fever Vaccines Sales (M Doses) by Source (2024-2029)
  • Table 51. Global Classical Swine Fever Vaccines Sales Market Share by Source (2018-2023)
  • Table 52. Global Classical Swine Fever Vaccines Sales Market Share by Source (2024-2029)
  • Table 53. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Source (2018-2023)
  • Table 54. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Source (2024-2029)
  • Table 55. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2018-2023)
  • Table 56. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2024-2029)
  • Table 57. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Source (2018-2023)
  • Table 58. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Source (2024-2029)
  • Table 59. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2018-2023)
  • Table 60. Global Classical Swine Fever Vaccines Sales (M Doses) by Sales Channel (2024-2029)
  • Table 61. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2018-2023)
  • Table 62. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2024-2029)
  • Table 63. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Sales Channel (2018-2023)
  • Table 64. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Sales Channel (2024-2029)
  • Table 65. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2018-2023)
  • Table 66. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2024-2029)
  • Table 67. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Sales Channel (2018-2023)
  • Table 68. Global Classical Swine Fever Vaccines Price (US$/K Doses) by Sales Channel (2024-2029)
  • Table 69. WINSUN Company Information
  • Table 70. WINSUN Description and Business Overview
  • Table 71. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 72. WINSUN Classical Swine Fever Vaccines Product
  • Table 73. Boehringer Ingelheim Company Information
  • Table 74. Boehringer Ingelheim Description and Business Overview
  • Table 75. Boehringer Ingelheim Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 76. Boehringer Ingelheim Classical Swine Fever Vaccines Product
  • Table 77. CAHIC Company Information
  • Table 78. CAHIC Description and Business Overview
  • Table 79. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 80. CAHIC Classical Swine Fever Vaccines Product
  • Table 81. SPAH Company Information
  • Table 82. SPAH Description and Business Overview
  • Table 83. SPAH Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 84. SPAH Classical Swine Fever Vaccines Product
  • Table 85. Merck Company Information
  • Table 86. Merck Description and Business Overview
  • Table 87. Merck Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 88. Merck Classical Swine Fever Vaccines Product
  • Table 89. Ceva Company Information
  • Table 90. Ceva Description and Business Overview
  • Table 91. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 92. Ceva Classical Swine Fever Vaccines Product
  • Table 93. Harbin Veterinary Research Institute Company Information
  • Table 94. Harbin Veterinary Research Institute Description and Business Overview
  • Table 95. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 96. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product
  • Table 97. Qilu Animal Health Products Factory Company Information
  • Table 98. Qilu Animal Health Products Factory Description and Business Overview
  • Table 99. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 100. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product
  • Table 101. Ringpu Biology Company Information
  • Table 102. Ringpu Biology Description and Business Overview
  • Table 103. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 104. Ringpu Biology Classical Swine Fever Vaccines Product
  • Table 105. DHN Company Information
  • Table 106. DHN Description and Business Overview
  • Table 107. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 108. DHN Classical Swine Fever Vaccines Product
  • Table 109. CAVAC Company Information
  • Table 110. CAVAC Description and Business Overview
  • Table 111. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 112. CAVAC Classical Swine Fever Vaccines Product
  • Table 113. Komipharm Company Information
  • Table 114. Komipharm Description and Business Overview
  • Table 115. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 116. Komipharm Classical Swine Fever Vaccines Product
  • Table 117. Agrovet Company Information
  • Table 118. Agrovet Description and Business Overview
  • Table 119. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 120. Agrovet Classical Swine Fever Vaccines Product
  • Table 121. Bioveta Company Information
  • Table 122. Bioveta Description and Business Overview
  • Table 123. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 124. Bioveta Classical Swine Fever Vaccines Product
  • Table 125. Jinyu Bio-Technology Company Information
  • Table 126. Jinyu Bio-Technology Description and Business Overview
  • Table 127. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 128. Jinyu Bio-Technology Classical Swine Fever Vaccines Product
  • Table 129. Institutul Pasteur Company Information
  • Table 130. Institutul Pasteur Description and Business Overview
  • Table 131. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 132. Institutul Pasteur Classical Swine Fever Vaccines Product
  • Table 133. MVP Company Information
  • Table 134. MVP Description and Business Overview
  • Table 135. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 136. MVP Classical Swine Fever Vaccines Product
  • Table 137. Tecon Company Information
  • Table 138. Tecon Description and Business Overview
  • Table 139. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2019-2023)
  • Table 140. Tecon Classical Swine Fever Vaccines Product
  • Table 141. Key Raw Materials Lists
  • Table 142. Raw Materials Key Suppliers Lists
  • Table 143. Classical Swine Fever Vaccines Distributors List
  • Table 144. Classical Swine Fever Vaccines Customers List
  • Table 145. Classical Swine Fever Vaccines Market Trends
  • Table 146. Classical Swine Fever Vaccines Market Drivers
  • Table 147. Classical Swine Fever Vaccines Market Challenges
  • Table 148. Classical Swine Fever Vaccines Market Restraints
  • Table 149. Research Programs/Design for This Report
  • Table 150. Key Data Information from Secondary Sources
  • Table 151. Key Data Information from Primary Sources
  • Table 152. Authors List of This Report
  • Table 153. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Product Picture of Classical Swine Fever Vaccines
  • Figure 2. Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029) & (US$ Million)
  • Figure 3. Global Classical Swine Fever Vaccines Market Share by Source: 2022
  • Figure 4. Global Classical Swine Fever Vaccines Market Share by Source: 2029
  • Figure 5. Tissue Culture Origin Product Picture
  • Figure 6. Cell Line Origin Product Picture
  • Figure 7. Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029) & (US$ Million)
  • Figure 8. Global Classical Swine Fever Vaccines Market Share by Sales Channel: 2022
  • Figure 9. Global Classical Swine Fever Vaccines Market Share by Sales Channel: 2029
  • Figure 10. Global Classical Swine Fever Vaccines Revenue, (US$ Million), 2018 VS 2023 VS 2029
  • Figure 11. Global Classical Swine Fever Vaccines Market Size (2018-2029) & (US$ Million)
  • Figure 12. Global Classical Swine Fever Vaccines Sales (2018-2029) & (M Doses)
  • Figure 13. Global Classical Swine Fever Vaccines Average Price (US$/K Doses) & (2018-2029)
  • Figure 14. Classical Swine Fever Vaccines Report Years Considered
  • Figure 15. Classical Swine Fever Vaccines Sales Share by Manufacturers in 2022
  • Figure 16. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers in 2022
  • Figure 17. Global 5 Largest Classical Swine Fever Vaccines Players: Market Share by Revenue in Classical Swine Fever Vaccines in 2022
  • Figure 18. Global 10 Largest Classical Swine Fever Vaccines Players: Market Share by Revenue in Classical Swine Fever Vaccines in 2022
  • Figure 19. Global Classical Swine Fever Vaccines Market Size by Region (US$ Million): 2018-2029
  • Figure 20. North America Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029)
  • Figure 21. North America Classical Swine Fever Vaccines Revenue Market Share by Country (2018-2029)
  • Figure 22. U.S. Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 23. Canada Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 24. Mexico Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 25. Europe Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029)
  • Figure 26. Europe Classical Swine Fever Vaccines Revenue Market Share by Country (2018-2029)
  • Figure 27. Germany Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 28. France Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 29. U.K. Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 30. Italy Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 31. Russia Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 32. Asia Pacific Classical Swine Fever Vaccines Sales Market Share by Region (2018-2029)
  • Figure 33. Asia Pacific Classical Swine Fever Vaccines Revenue Market Share by Region (2018-2029)
  • Figure 34. China Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 35. Japan Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 36. South Korea Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 37. India Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 38. Australia Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 39. Southeast Asia Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 40. South America Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029)
  • Figure 41. Brazil Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 42. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share by Country (2018-2029)
  • Figure 43. Middle East and Africa Classical Swine Fever Vaccines Revenue Market Share by Country (2018-2029)
  • Figure 44. Middle East Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 45. Africa Classical Swine Fever Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
  • Figure 46. Global Sales Market Share of Classical Swine Fever Vaccines by Source (2018-2029)
  • Figure 47. Global Revenue Market Share of Classical Swine Fever Vaccines by Source (2018-2029)
  • Figure 48. Global Sales Market Share of Classical Swine Fever Vaccines by Sales Channel (2018-2029)
  • Figure 49. Global Revenue Market Share of Classical Swine Fever Vaccines by Sales Channel (2018-2029)
  • Figure 50. Classical Swine Fever Vaccines Value Chain
  • Figure 51. Classical Swine Fever Vaccines Production Process
  • Figure 52. Channels of Distribution
  • Figure 53. Distributors Profiles
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed
目次

The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2022 and is anticipated to reach US$ 211 million by 2029, witnessing a CAGR of 4.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Classical Swine Fever Vaccines is estimated to increase from $ 12.29 million in 2023 to reach $ 14.86 million by 2029, at a CAGR of 3.22% during the forecast period of 2023 through 2029.

Asia-Pacific market for Classical Swine Fever Vaccines is estimated to increase from $ 104 million in 2023 to reach $ 140.7 million by 2029, at a CAGR of 5.17% during the forecast period of 2023 through 2029.

The major global manufacturers of Classical Swine Fever Vaccines include: WINSUN, Boehringer Ingelheim, CAHIC, SPAH, Merck, Ceva, Harbin Veterinary Research Institute, and Qilu Animal Health Products Factory, etc. In 2022, the world's top five vendors accounted for approximately 50.49% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Classical Swine Fever Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Classical Swine Fever Vaccines.

The Classical Swine Fever Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Classical Swine Fever Vaccines market comprehensively. Regional market sizes, concerning products by Source, by Sales Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Classical Swine Fever Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Source, by Sales Channel, and by regions.

By Company

  • WINSUN
  • Boehringer Ingelheim
  • CAHIC
  • SPAH
  • Merck
  • Ceva
  • Harbin Veterinary Research Institute
  • Qilu Animal Health Products Factory
  • Ringpu Biology
  • DHN
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • Jinyu Bio-Technology
  • Institutul Pasteur
  • MVP
  • Tecon

Segment by Source

  • Tissue Culture Origin
  • Cell Line Origin

Segment by Sales Channel

  • Government Tender
  • Market Sales

Consumption by Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Classical Swine Fever Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Classical Swine Fever Vaccines Market Overview

  • 1.1 Product Definition
  • 1.2 Classical Swine Fever Vaccines by Source
    • 1.2.1 Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029)
    • 1.2.2 Tissue Culture Origin
    • 1.2.3 Cell Line Origin
  • 1.3 Classical Swine Fever Vaccines by Sales Channel
    • 1.3.1 Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029)
    • 1.3.2 Government Tender
    • 1.3.3 Market Sales
  • 1.4 Global Classical Swine Fever Vaccines Market Size Estimates and Forecasts
    • 1.4.1 Global Classical Swine Fever Vaccines Revenue 2018-2029
    • 1.4.2 Global Classical Swine Fever Vaccines Sales 2018-2029
    • 1.4.3 Global Classical Swine Fever Vaccines Market Average Price (2018-2029)
  • 1.5 Assumptions and Limitations

2 Classical Swine Fever Vaccines Market Competition by Manufacturers

  • 2.1 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2018-2023)
  • 2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2019-2023)
  • 2.3 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2019-2023)
  • 2.4 Global Key Players of Classical Swine Fever Vaccines, Industry Ranking, 2021 VS 2022
  • 2.5 Global Key Manufacturers of Classical Swine Fever Vaccines, Area Served & Headquarters
  • 2.6 Global Key Manufacturers of Classical Swine Fever Vaccines, Product Type & Application
  • 2.7 Founded Data of Global Key Classical Swine Fever Vaccines Manufacturers
  • 2.8 Global Classical Swine Fever Vaccines Market Competitive Situation and Trends
    • 2.8.1 Global Classical Swine Fever Vaccines Market Concentration Rate
    • 2.8.2 The Global 5 and 10 Largest Classical Swine Fever Vaccines Players Market Share by Revenue
    • 2.8.3 Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)

3 Global Classical Swine Fever Vaccines Market Scenario by Region

  • 3.1 Global Classical Swine Fever Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
  • 3.2 Global Classical Swine Fever Vaccines Sales by Region: 2018-2029
    • 3.2.1 Global Classical Swine Fever Vaccines Sales by Region: 2018-2023
    • 3.2.2 Global Classical Swine Fever Vaccines Sales by Region: 2024-2029
  • 3.3 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2029
    • 3.3.1 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2023
    • 3.3.2 Global Classical Swine Fever Vaccines Revenue by Region: 2024-2029
  • 3.4 North America Classical Swine Fever Vaccines Market Facts & Figures by Country
    • 3.4.1 North America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029
    • 3.4.2 North America Classical Swine Fever Vaccines Sales by Country (2018-2029)
    • 3.4.3 North America Classical Swine Fever Vaccines Revenue by Country (2018-2029)
    • 3.4.4 U.S.
    • 3.4.5 Canada
    • 3.4.6 Mexico
  • 3.5 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country
    • 3.5.1 Europe Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029
    • 3.5.2 Europe Classical Swine Fever Vaccines Sales by Country (2018-2029)
    • 3.5.3 Europe Classical Swine Fever Vaccines Revenue by Country (2018-2029)
    • 3.5.4 Germany
    • 3.5.5 France
    • 3.5.6 U.K.
    • 3.5.7 Italy
    • 3.5.8 Russia
  • 3.6 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Region
    • 3.6.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Region: 2018 VS 2022 VS 2029
    • 3.6.2 Asia Pacific Classical Swine Fever Vaccines Sales by Region (2018-2029)
    • 3.6.3 Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2018-2029)
    • 3.6.4 China
    • 3.6.5 Japan
    • 3.6.6 South Korea
    • 3.6.7 India
    • 3.6.8 Australia
    • 3.6.9 Southeast Asia
  • 3.7 South America Classical Swine Fever Vaccines Market Facts & Figures by Country
    • 3.7.1 South America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029
    • 3.7.2 South America Classical Swine Fever Vaccines Sales by Country (2018-2029)
    • 3.7.3 South America Classical Swine Fever Vaccines Revenue by Country
    • 3.7.4 Brazil
  • 3.8 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country
    • 3.8.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029
    • 3.8.2 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2029)
    • 3.8.3 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country
    • 3.8.4 Middle East
    • 3.8.5 Africa

4 Segment by Source

  • 4.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2029)
    • 4.1.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2023)
    • 4.1.2 Global Classical Swine Fever Vaccines Sales by Source (2024-2029)
    • 4.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Source (2018-2029)
  • 4.2 Global Classical Swine Fever Vaccines Revenue by Source (2018-2029)
    • 4.2.1 Global Classical Swine Fever Vaccines Revenue by Source (2018-2023)
    • 4.2.2 Global Classical Swine Fever Vaccines Revenue by Source (2024-2029)
    • 4.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2018-2029)
  • 4.3 Global Classical Swine Fever Vaccines Price by Source (2018-2029)

5 Segment by Sales Channel

  • 5.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2029)
    • 5.1.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023)
    • 5.1.2 Global Classical Swine Fever Vaccines Sales by Sales Channel (2024-2029)
    • 5.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2018-2029)
  • 5.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2029)
    • 5.2.1 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2023)
    • 5.2.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2024-2029)
    • 5.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2018-2029)
  • 5.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2018-2029)

6 Key Companies Profiled

  • 6.1 WINSUN
    • 6.1.1 WINSUN Company Information
    • 6.1.2 WINSUN Description and Business Overview
    • 6.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio
  • 6.2 Boehringer Ingelheim
    • 6.2.1 Boehringer Ingelheim Company Information
    • 6.2.2 Boehringer Ingelheim Description and Business Overview
    • 6.2.3 Boehringer Ingelheim Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.2.4 Boehringer Ingelheim Classical Swine Fever Vaccines Product Portfolio
  • 6.3 CAHIC
    • 6.3.1 CAHIC Company Information
    • 6.3.2 CAHIC Description and Business Overview
    • 6.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio
  • 6.4 SPAH
    • 6.4.1 SPAH Company Information
    • 6.4.2 SPAH Description and Business Overview
    • 6.4.3 SPAH Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.4.4 SPAH Classical Swine Fever Vaccines Product Portfolio
  • 6.5 Merck
    • 6.5.1 Merck Company Information
    • 6.5.2 Merck Description and Business Overview
    • 6.5.3 Merck Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.5.4 Merck Classical Swine Fever Vaccines Product Portfolio
  • 6.6 Ceva
    • 6.6.1 Ceva Company Information
    • 6.6.2 Ceva Description and Business Overview
    • 6.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.6.4 Ceva Classical Swine Fever Vaccines Product Portfolio
  • 6.7 Harbin Veterinary Research Institute
    • 6.7.1 Harbin Veterinary Research Institute Company Information
    • 6.7.2 Harbin Veterinary Research Institute Description and Business Overview
    • 6.7.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.7.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio
  • 6.8 Qilu Animal Health Products Factory
    • 6.8.1 Qilu Animal Health Products Factory Company Information
    • 6.8.2 Qilu Animal Health Products Factory Description and Business Overview
    • 6.8.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.8.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio
  • 6.9 Ringpu Biology
    • 6.9.1 Ringpu Biology Company Information
    • 6.9.2 Ringpu Biology Description and Business Overview
    • 6.9.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.9.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio
  • 6.10 DHN
    • 6.10.1 DHN Company Information
    • 6.10.2 DHN Description and Business Overview
    • 6.10.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.10.4 DHN Classical Swine Fever Vaccines Product Portfolio
  • 6.11 CAVAC
    • 6.11.1 CAVAC Company Information
    • 6.11.2 CAVAC Description and Business Overview
    • 6.11.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.11.4 CAVAC Classical Swine Fever Vaccines Product Portfolio
  • 6.12 Komipharm
    • 6.12.1 Komipharm Company Information
    • 6.12.2 Komipharm Description and Business Overview
    • 6.12.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.12.4 Komipharm Classical Swine Fever Vaccines Product Portfolio
  • 6.13 Agrovet
    • 6.13.1 Agrovet Company Information
    • 6.13.2 Agrovet Description and Business Overview
    • 6.13.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.13.4 Agrovet Classical Swine Fever Vaccines Product Portfolio
  • 6.14 Bioveta
    • 6.14.1 Bioveta Company Information
    • 6.14.2 Bioveta Description and Business Overview
    • 6.14.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.14.4 Bioveta Classical Swine Fever Vaccines Product Portfolio
  • 6.15 Jinyu Bio-Technology
    • 6.15.1 Jinyu Bio-Technology Company Information
    • 6.15.2 Jinyu Bio-Technology Description and Business Overview
    • 6.15.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.15.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio
  • 6.16 Institutul Pasteur
    • 6.16.1 Institutul Pasteur Company Information
    • 6.16.2 Institutul Pasteur Description and Business Overview
    • 6.16.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.16.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio
  • 6.17 MVP
    • 6.17.1 MVP Company Information
    • 6.17.2 MVP Description and Business Overview
    • 6.17.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.17.4 MVP Classical Swine Fever Vaccines Product Portfolio
  • 6.18 Tecon
    • 6.18.1 Tecon Company Information
    • 6.18.2 Tecon Description and Business Overview
    • 6.18.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023)
    • 6.18.4 Tecon Classical Swine Fever Vaccines Product Portfolio

7 Industry Chain and Sales Channels Analysis

  • 7.1 Classical Swine Fever Vaccines Industry Chain Analysis
  • 7.2 Classical Swine Fever Vaccines Key Raw Materials
    • 7.2.1 Key Raw Materials
    • 7.2.2 Raw Materials Key Suppliers
  • 7.3 Classical Swine Fever Vaccines Production Mode & Process
  • 7.4 Classical Swine Fever Vaccines Sales and Marketing
    • 7.4.1 Classical Swine Fever Vaccines Sales Channels
    • 7.4.2 Classical Swine Fever Vaccines Distributors
  • 7.5 Classical Swine Fever Vaccines Customers

8 Classical Swine Fever Vaccines Market Dynamics

  • 8.1 Classical Swine Fever Vaccines Industry Trends
  • 8.2 Classical Swine Fever Vaccines Market Drivers
  • 8.3 Classical Swine Fever Vaccines Market Challenges
  • 8.4 Classical Swine Fever Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

  • 10.1 Methodology/Research Approach
    • 10.1.1 Research Programs/Design
    • 10.1.2 Market Size Estimation
    • 10.1.3 Market Breakdown and Data Triangulation
  • 10.2 Data Source
    • 10.2.1 Secondary Sources
    • 10.2.2 Primary Sources
  • 10.3 Author List
  • 10.4 Disclaimer